American Journal of Clinical Oncology: Cancer Clinical Trials
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.8 | Q4 | 21.0% | 0.647 | Q3 | 70.2% |
| 2024 | 1.8 | Q4 | 23.0% | 0.696 | Q3 | 73.4% |
| 2023 | 1.6 | Q4 | 22.2% | 0.711 | Q2 | 76.2% |
| 2022 | 2.6 | Q3 | 35.7% | 0.916 | Q2 | 84.2% |
| 2021 | 2.8 | Q4 | 38.7% | 0.795 | Q2 | 80.9% |
| 2020 | — | — | 0.896 | Q2 | 82.7% | |
| 2019 | — | — | 1.060 | Q2 | 86.9% | |
| 2018 | — | — | 1.090 | Q2 | 86.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0277-3732
ISSN
1537-453X
country
UScoverage
1982-2026